Healthcare Sales & Marketing Network News: gene expression

Searching News Database: gene expression

HSMN NewsFeed - 17 Jul 2024
Alltrna Announces Updates to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 May 2024
Chroma Medicine Announces Appointment of Jenny Marlowe, Ph.D., as Chief Development Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 May 2024
Alcyone Therapeutics Announces Appointment of Dr. Norbert Riedel as Chairman of the Board and Dr. Kathrin Meyer as Chief Scientific Officer and Head of Research & Development
Biopharmaceuticals Drug Delivery Neurology Personnel

HSMN NewsFeed - 19 Jun 2023
Sirnaomics Advances STP705 for Squamous Cell Carcinoma In Situ into Late-Stage Clinical Development
Biopharmaceuticals Oncology

HSMN NewsFeed - 22 Mar 2023
Flare Therapeutics Announces Oversubscribed $123 Million Series B Financing
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 1 Mar 2023
Chroma Medicine Secures $135M in Series B Financing to Advance Breakthrough Epigenetic Editing Technology and Expand Pipeline of Durable Precision Genomic Medicines
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 2 Feb 2023
Tezspire(R) Approved for Self-Administration in the U.S. with a New Pre-Filled Pen
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 22 Nov 2022
U.S. Food and Drug Administration Approves CSL's Hemgenix(R) eEtranacogene dezaparvovec-drlb), the First Gene Therapy for Hemophilia B
Biopharmaceuticals FDA

HSMN NewsFeed - 29 Jul 2022
Novasenta Completes $40 million Series A to Advance Novel Cancer Therapeutics
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 17 May 2022
Remix Therapeutics Closes $70 Million Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 30 Mar 2022
Omega Therapeutics Strengthens Team With Key Management Appointments To Support Its Growth
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Dec 2021
Lilly and Foghorn Announce Strategic Collaboration for Novel Oncology Targets Using Foghorn's Proprietary Gene Traffic Control(R) Platform
Biopharmaceuticals Oncology

HSMN NewsFeed - 17 Aug 2021
Remix Therapeutics Names Peter Smith, PhD, as President and Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Jul 2021
Viracta Therapeutics Announces the Appointment of Ayman El-Guindy, Ph.D., as Chief Scientific Officer and Key Additions to Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Dec 2020
Remix Therapeutics Launches with $81 Million Financing to Develop Small Molecule Therapies Designed to Reprogram RNA Processing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 10 Nov 2020
Tezepelumab NAVIGATOR Phase 3 Trial Met Primary Endpoint Of A Statistically Significant And Clinically Meaningful Reduction In Exacerbations In A Broad Population Of Patients With Severe Asthma
Biopharmaceuticals

HSMN NewsFeed - 25 Sep 2020
Study Reveals Blood-Based Host Response Test Can Accurately Predict Respiratory Viral Infection in Pre-Symptomatic Patients
Diagnostics

HSMN NewsFeed - 11 Aug 2020
Wouter Meuleman Promoted to Partner of Illumina Ventures
Biopharmaceuticals Diagnostics Venture Capital Personnel

HSMN NewsFeed - 29 Jul 2020
Biotech Vico Therapeutics raises $31 million (€27 million) in Series A financing round to advance therapies for rare central nervous system diseases
Biopharmaceuticals Neurology Venture Capital

HSMN NewsFeed - 26 Mar 2020
Immunexpress Receives CE Mark and Signs European Commercialization Partnership for SeptiCyte(R) RAPID
Diagnostics Regulatory

HSMN NewsFeed - 3 Mar 2020
DxTerity Receives CE Mark for DxCollect(R) Fingerstick Blood RNA Stabilization Device
Devices Diagnostics Regulatory

HSMN NewsFeed - 24 Feb 2020
Dovetail Genomics Introduces New Dovetail(TM) Micro-C and HiChIP Kits
Diagnostics Product Launch

HSMN NewsFeed - 3 Jan 2020
Breast Cancer Patients in Germany Now have Insurance Coverage for MammaPrint(R) Testing through Techniker Krankenkasse
Diagnostics Oncology Reimbursement

HSMN NewsFeed - 11 Dec 2019
Caris Life Sciences Launches First Ever Molecular AI Product: A Clinical Genomic Profiling Similarity Score
Diagnostics Oncology Product Launch

HSMN NewsFeed - 25 Nov 2019
INHIBITOR Therapeutics Submits Investigational New Drug Application for Treatment of Patients with Late-Stage Prostate Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 25 Nov 2019
Alkermes Completes Acquisition of Rodin Therapeutics
Biopharmaceuticals Neurology Mergers & Acquisitions

HSMN NewsFeed - 11 Oct 2019
Transplant Genomics, Inc. Confirms TruGraf(R) Will Receive Medicare Coverage Effective November 25, 2019
Diagnostics Reimbursement

HSMN NewsFeed - 4 Sep 2019
REGENXBIO Announces Exclusive Worldwide Option and License Agreement with Clearside Biomedical for Evaluation of In-Office Delivery Platform for RGX-314
Biopharmaceuticals Drug Delivery Licensing

HSMN NewsFeed - 26 Jun 2019
Encoded Therapeutics, Inc. Announces $104 Million Series C Financing to Advance Lead Gene Therapy Program in Dravet Syndrome and Unveils its Precision Gene Therapy Platform
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 30 May 2019
Caris Life Sciences Partners with Debiopharm International SA to Develop Companion Diagnostic for Detection of Rare FGFR Fusions Using Novel Molecular Intelligence (MI) Transcriptome(TM)
Diagnostics Oncology

HSMN NewsFeed - 10 Apr 2019
Phio Pharmaceuticals Appoints Dr. John Barrett as Chief Development Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 20 Dec 2018
Merck KGaA, Darmstadt, Germany, Assigns Chimeric Antigen Receptor T-cell (CAR-T) Rights to Intrexon
Biopharmaceuticals Oncology Licensing

HSMN NewsFeed - 13 Nov 2018
HOX Therapeutics Appoints Karl Keegan as Chief Executive Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 9 Oct 2018
Agendia Announces Level 1 Inclusion of MammaPrint(R) Breast Cancer Test in Updated National Comprehensive Cancer Network(R) (NCCN) Guidelines
Diagnostics Oncology Personalized Medicine

HSMN NewsFeed - 18 Sep 2018
Agendia and Genecast Biotechnology Partner to Launch MammaPrint(R) and BluePrint(R) in China
Diagnostics Personalized Medicine Oncology Product Launch

HSMN NewsFeed - 14 Jun 2018
New England Biolabs(R) Launches New NEBNext(R) Single Cell/Low Input RNA Library Prep Kit for Increased Transcript Detection with Ultra-low Input Amounts
Diagnostics Product Launch

HSMN NewsFeed - 10 May 2018
Interpace Diagnostics Announces Expanded Coverage Among Blue Cross Blue Shield Plans
Diagnostics Oncology Reimbursement

HSMN NewsFeed - 2 May 2018
Refuge Biotechnologies Completes $25 Million Series B Financing, Appoints CSO to Advance the Development of Intelligent Cell Therapies in Oncology
Biopharmaceuticals Oncology Venture Capital Personnel

HSMN NewsFeed - 1 May 2018
Agendia's MammaPrint(R) Receives Positive Coverage Decisions from Three Major Private Healthcare Insurers
Diagnostics Personalized Medicine Oncology Reimbursement

HSMN NewsFeed - 30 Mar 2018
Epic Sciences and Genomic Health Announce Favorable Draft Local Coverage Determination (LCD) on Medicare Coverage for Use of the Oncotype DX(R) AR-V7 Nucleus Detect(TM) Test in Patients with Metastatic Castration-Resistant Prostate Cancer
Diagnostics Oncology Reimbursement

HSMN NewsFeed - 7 Mar 2018
New Blood Test to Accurately Detect Fibromyalgia Now Available from Data Science Company IQuity
Diagnostics Product Launch

HSMN NewsFeed - 26 Feb 2018
Genomic Health Expands Offering to Prostate Cancer Patients with Launch of Oncotype DX(R) AR-V7 Nucleus Detect(TM) Test to Predict Treatment Response in Metastatic Disease
Diagnostics Oncology Product Launch

HSMN NewsFeed - 23 Jan 2018
Skyhawk Therapeutics Launches With $8 Million in Seed Financing to Advance Its Novel Platform and Portfolio of Small Molecules That Correct RNA Expression
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 6 Dec 2017
Sirnaomics' Leading siRNA Therapeutic Candidate, STP705, Granted Orphan Designation for Treatment of Cholangiocarcinoma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 4 Sep 2017
Eyevensys Appoints Dr Ronald R. Buggage as Chief Medical Officer
Biopharmaceuticals Ophthalmology Personnel

HSMN NewsFeed - 14 Aug 2017
Synthorx Appoints Marcos Milla, Ph.D. as Senior Vice President of Research
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Jul 2017
DermTech Secures Billing Codes for its Proprietary Melanoma Test
Diagnostics Oncology Reimbursement

HSMN NewsFeed - 12 Jul 2017
Viking Therapeutics Completes Enrollment in Phase 2 Study of VK5211 in Patients Recovering from Hip Fracture
Biopharmaceuticals Orthopaedic

HSMN NewsFeed - 13 Jun 2017
Regulus Promotes Mark Deeg, M.D. PhD to Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Jun 2017
Regulus Announces Pipeline Updates and Advancements
Biopharmaceuticals

HSMN NewsFeed - 1 Jun 2017
SPINRAZA(R) (nusinersen) Approved in the European Union
Biopharmaceuticals Regulatory

HSMN NewsFeed - 18 May 2017
Biotheranostics Appoints Don Hardison as New CEO
Diagnostics Personalized Medicine Personnel

HSMN NewsFeed - 21 Mar 2017
Eyevensys Appoints Leading Life Sciences Executive and Ophthalmology Expert Dr. Garth Cumberlidge as Chairman
Biopharmaceuticals Devices Ophthalmology Personnel

HSMN NewsFeed - 1 Mar 2017
Veracyte Announces Executive Promotions
Diagnostics Oncology Personnel

HSMN NewsFeed - 9 Feb 2017
AAVP Biosystems Hires Mark Shapiro, M.D., Ph.D. as Chief Medical Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 26 Dec 2016
SPINRAZA(TM) (nusinersen) Approved in U.S. to Treat Broad Range of Patients with Spinal Muscular Atrophy
Biopharmaceuticals FDA

HSMN NewsFeed - 9 Dec 2016
Genomic Health Announces Results from Multiple Oncotype DX(R) Studies, Reinforcing its Impact in Delivering Precision Medicine to Breast Cancer Patients Around the World
Diagnostics Personalized Medicine Oncology

HSMN NewsFeed - 27 Oct 2016
The Myriad myPath(R) Melanoma Test Effectively Diagnosed Patients in the Largest Outcomes-Based Study for a Melanoma Diagnostic
Diagnostics Dermatology Oncology

HSMN NewsFeed - 24 Oct 2016
Personal Genome Diagnostics Launches RNAcomplete(TM) Allowing Co-Extraction and Analysis of RNA and DNA from a Single FFPE Tissue Sample
Diagnostics Oncology Product Launch

HSMN NewsFeed - 6 Oct 2016
Interpace Diagnostics Launches New Streamlined Molecular Product for Pancreatic Cysts
Diagnostics Oncology Product Launch

HSMN NewsFeed - 23 May 2016
Interpace Diagnostics Presents New Clinical Utility Data at Digestive Disease Week
Diagnostic Gastroenterology Oncology

HSMN NewsFeed - 13 May 2016
WaferGen Bio-systems and Takara Bio Inc. Announce Merger Agreement
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 6 May 2016
Epizyme Continues to Build Senior Leadership Team with Appointment of Matthew Ros as Chief Operating Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 5 May 2016
Investigational Gene-Based Therapy for Alpha-1 Antitrypsin (AAT) Deficiency Demonstrates Durable Response at Five Years
Biopharmaceuticals

HSMN NewsFeed - 18 Apr 2016
Interpace Diagnostics Announces New Coding by Novitas Solutions for PancraGen(TM)
Diagnostics Oncology Reimbursement

HSMN NewsFeed - 19 Feb 2016
Veracyte Announces Publication of Study Reinforcing the Clinical Utility of the Afirma(R) Gene Expression Classifier in Thyroid Cancer Diagnosis
Diagnostics Oncology

HSMN NewsFeed - 17 Feb 2016
Interpace Diagnostics Receives Medicare Coverage For Its ThyraMIR(TM) Micro RNA Gene Expression Classifer
Diagnostics Oncology Reimbursement

HSMN NewsFeed - 29 Jan 2016
FDA Approves Eisai's Halaven(R) (eribulin mesylate) Injection for the Treatment of Patients with Advanced Liposarcoma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 22 Jan 2016
Veracyte Announces Publication of Long-Term Clinical Utility Study for the Afirma(R) Gene Expression Classifier
Diagnostics Oncology

HSMN NewsFeed - 20 Jan 2016
Interpace Diagnostics Announces New Medicare Local Coverage Determination for Molecular Testing of Pancreatic Cysts
Diagnostics Oncology Reimbursement

HSMN NewsFeed - 12 Jan 2016
Interpace Diagnostics' New Molecular Test for Thyroid Nodules Now Available Through LabCorp
Diagnostics Oncology

HSMN NewsFeed - 10 Nov 2015
miRagen Therapeutics Secures $41 million Series C Financing to Advance Two MicroRNA Programs into Clinical Trials
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 3 Nov 2015
Castle Biosciences Announces the Appointment of Federico Monzon, M.D., FCAP as Chief Medical Officer
Diagnostics Oncology Personnel

HSMN NewsFeed - 27 Oct 2015
DermTech Announces Expansion of Direct US Sales Team
Diagnostics Dermatology Oncology Personnel

HSMN NewsFeed - 25 Aug 2015
Regulus Appoints Michael Huang, M.D. as Vice President, Clinical Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Aug 2015
Veracyte, Inc. Appoints Dr. Neil M. Barth as Chief Medical Officer
Diagnostics Oncology Personnel

HSMN NewsFeed - 5 Aug 2015
Metacrine Raises $36 Million in Series A Financing
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 15 Jul 2015
OncoCyte Announces Appointment of Andy Arno to Board of Directors
Diagnostics Oncology Personnel

HSMN NewsFeed - 16 Jun 2015
William Annett Named Chief Executive Officer of OncoCyte Corporation
Diagnostics Oncology Personnel

HSMN NewsFeed - 11 Jun 2015
XTuit Pharmaceuticals Closes $22 Million Series A Financing to Advance Novel Microenvironmental Modulators for Cancers and Fibrotic Disorders
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 11 Jun 2015
Biontech Launches Mammatyper(R) Breast Cancer Diagnostic Test in Europe
Diagnostics Personalized Medicine Oncology Product Launch

HSMN NewsFeed - 2 Jun 2015
ZIOPHARM Announces Caesar J. Belbel, Chief Legal Officer, Appointed Chief Operating Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 14 May 2015
OncoCyte Corporation Completes Equity Financing Round
Diagnostics Oncology Venture Capital

HSMN NewsFeed - 2 Dec 2014
Study Shows Prolaris(R) Could Save Healthcare System $6 Billion Over 10 Years
Diagnostics Urology Oncology

HSMN NewsFeed - 7 Nov 2014
Myriad myPath(TM) Melanoma Improves Diagnosis and Treatment Plans
Diagnostics Dermatology Oncology

HSMN NewsFeed - 9 Sep 2014
Myriad myPath(TM) Melanoma Test Reduced Indeterminate Cases by 76 Percent and Changed Treatment in 35 Percent of Cases
Diagnostics Oncology

HSMN NewsFeed - 13 Aug 2014
Castle Biosciences Announces $11.8 Million Financing
Diagnostics Venture Capital

HSMN NewsFeed - 16 Jun 2014
Regulus Appoints Paul C. Grint, M.D. as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Jun 2014
Myriad myPath(TM) Melanoma Test Improves the Reliability of Melanoma Diagnosis
Diagnostics Dermatology Oncology

HSMN NewsFeed - 25 Apr 2014
KCI Presents New Clinical and Economic Evidence at SAWC/WHS Spring 2014 Conference
Devices Wound Care

HSMN NewsFeed - 9 Apr 2014
CardioDx and Medison Israel Enter Into an Exclusive Corus(R) CAD Product Marketing and Sales Agreement
Diagnostics Cardiology Distribution

HSMN NewsFeed - 17 Mar 2014
Veracyte, Inc. Appoints Julie A. Brooks as Executive Vice President, General Counsel and Secretary; and Andy Thorson as Executive Vice President, Corporate Strategy and Business Development
Diagnostics Personnel

HSMN NewsFeed - 11 Mar 2014
Exosome Diagnostics Raises $27 Million in Series B Financing
Diagnostics Venture Capital

HSMN NewsFeed - 3 Mar 2014
Myriad Publishes Clinical Utility Study for Prolaris(R)
Diagnostics Urology

HSMN NewsFeed - 13 Feb 2014
Regulus Appoints Head of Regulus microMarkers(TM) R&D Division
Biopharmaceuticlas Personnel

HSMN NewsFeed - 29 Jan 2014
Genomic Health Announces Results of Oncotype DX(R) Colon Cancer Studies Presented at 2014 American Society of Clinical Oncology Gastrointestinal Cancer (ASCO GI) Symposium
Diagnostics Oncology

HSMN NewsFeed - 29 Jan 2014
Myriad's Prolaris(R) Test Significantly Modifies Treatment Decisions for Patients With Prostate Cancer
Diagnostics Oncology

HSMN NewsFeed - 9 Jan 2014
Biogen Idec and Sangamo BioSciences Announce Global Collaboration to Develop Treatments for Hemoglobinopathies
Biopharmaceuticals

HSMN NewsFeed - 1 Oct 2013
Genomic Health Announces Presentation of Oncotype DX(R) Studies Reinforcing Value of Tests in Guiding Treatment for Multiple Cancers
Diagnostics Oncology

HSMN NewsFeed - 27 Aug 2013
bioTheranostics Appoints Three Key Executives
Diagnostics Personalized Medicine Oncology Personnel

HSMN NewsFeed - 27 Aug 2013
Syndax Pharmaceuticals Secures $26.6 Million Series B Financing for Advancement of Epigenetic Therapies for Treatment-Resistant Cancers
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 26 Aug 2013
Sangamo BioSciences to Acquire Ceregene
Biopharmaceuticals Neurology Mergers & Acquisitions

HSMN NewsFeed - 20 Aug 2013
DermTech Raises $5.6 Million in Series B Financing
Diagnostics Oncology Venture Capital

HSMN NewsFeed - 1 Jul 2013
Illumina Applies CE Mark to MiSeqDx(TM) Cystic Fibrosis System
Diagnostics Regulatory

HSMN NewsFeed - 22 May 2013
Syros Pharmaceuticals Appoints Eric R. Olson, Ph.D. as Chief Scientific Officer
Biopharmaceuticals Personalized Medicine Personnel

HSMN NewsFeed - 20 May 2013
eFFECTOR Therapeutics Raises $45 Million in Series A Financing
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 15 May 2013
FANG(TM) Personalized Tumor Vaccine Stimulates Immune Response and More than Doubles Time to Recurrence in Patients with Advanced Stage Ovarian Cancer
Biopharmaceuticals Personalized Medicine Oncology

HSMN NewsFeed - 12 Apr 2013
Veracyte Announces Appointment of Shelly D. Guyer as Chief Financial Officer
Diagnostics Personnel

HSMN NewsFeed - 12 Mar 2013
Allegro Diagnostics Announces BronchoGen(TM) Genomic Test for Improved Diagnosis of Lung Cancer Successfully Achieves Clinical Validation
Diagnostics Oncology

HSMN NewsFeed - 30 Jan 2013
Mirna Therapeutics Inc. Appoints Clay B. Siegall, Ph.D., to Its Board of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 4 Jan 2013
Predictive Biosciences Appoints Diagnostics Industry Veteran Pierre Cassigneul as Chief Executive Officer
Diagnostics Oncology Urology Personnel

HSMN NewsFeed - 5 Nov 2012
Pathwork Diagnostics Inc. Appoints Lee McCracken as CEO
Diagnostics Oncology Personnel

HSMN NewsFeed - 24 Oct 2012
Mirna Therapeutics Secures $34.5 Million Series C Financing to Advance Oncology microRNA Pipeline into the Clinic
Biopharmaceuticals Oncology Venture Capital Personnel

HSMN NewsFeed - 27 Aug 2012
CardioDx Completes $58 Million Equity Financing
Diagnostics Cardiology Venture Capital

HSMN NewsFeed - 31 Jul 2012
CardioDx’s Corus CAD Gene Expression Test Performs Equally Well in Both Women and Men for the Assessment of Obstructive Coronary Artery Disease, Study Shows
Diagnostics Cardiology

HSMN NewsFeed - 26 Jun 2012
Allegro Diagnostics Appoints Clinical and Scientific Advisory Board Comprised of Experts in Pulmonology, Lung Cancer and Molecular Diagnostics
Diagnostics Oncology Personnel

HSMN NewsFeed - 1 Jun 2012
Agendia Announces Launch of ColoPrint for Colon Cancer Prognosis and Prediction
Diagnostics Personalized Medicine Oncology

HSMN NewsFeed - 26 Apr 2012
Epizyme Forms Strategic Partnership with Industry Leader in Epigenetic Therapies, Celgene Corporation, to Develop Personalized Therapeutics for Genetically-Defined Cancers
Biopharmaceuticals Oncology Personalized Medicine

HSMN NewsFeed - 24 Apr 2012
miRagen Therapeutics Secures $20 Million Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 5 Apr 2012
Richard T. Kloos, M.D., Joins Veracyte as Senior Medical Director
Diagnostics Personnel

HSMN NewsFeed - 27 Mar 2012
Constellation Pharmaceuticals Appoints Keith E. Dionne, Ph.D., as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Mar 2012
Everist Genomics Develops World's First Comprehensive Companion Diagnostics and Prognostics Portfolio for Early Diagnosis and Improved Treatment of Colorectal Cancer
Diagnostics Personalized Medicine Oncology

HSMN NewsFeed - 21 Feb 2012
Arno Therapeutics Receives Two Orphan-Drug Designations for AR-42 in Treatment of Central-Nervous-System Tumors
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 20 Jan 2012
Genzyme and Veracyte Announce Global Co-Promotion Agreement to Deliver Personalized Solution for Thyroid Patients
Diagnostics Endocrinology Oncology Personalized Medicine

HSMN NewsFeed - 6 Dec 2011
Agendia Introduces the SYMPHONY(TM) Breast Cancer Profile With Paraffin Embedded Tissue
Diagnostics Personalized Medicine Oncology

HSMN NewsFeed - 14 Nov 2011
Athersys Announces Recovery of All Rights to Cardiovascular Cell Therapy Program
Regenerative Medicine Cardiology

HSMN NewsFeed - 23 Aug 2011
Mirna Therapeutics Announces Completion of Financing Round
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 25 Jul 2011
St. Gallen International Breast Cancer Expert Panel Guidelines Include Oncotype DX(R) as Predictor of Chemotherapy Benefit
Diagnostics Personalized Medicine Oncology

HSMN NewsFeed - 23 Jun 2011
Jules A. Müsing Joins iBio’s Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Jun 2011
Constellation Pharmaceuticals Raises $15 Million in Additional Funding
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 3 Jun 2011
Breast Cancer Genomic Test Shown to Predict Patient Survival Following Adjuvant Chemotherapy
Diagnostics Personalized Medicine Oncology

HSMN NewsFeed - 24 May 2011
Centella Therapeutics Licenses Novel New Drug Designed to Enhance the Effectiveness of Cancer Treatment
Devices Biopharmaceuticals Oncology Licensing

HSMN NewsFeed - 18 May 2011
Regulus Therapeutics Expands Executive Team with Recent Appointments
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 May 2011
HTG Molecular Diagnostics Appoints John Lubniewski to Chief Business Officer
Diagnostics Personnel

HSMN NewsFeed - 21 Mar 2011
Regulus Therapeutics Appoints Lars Karlsson, M.D., Ph.D., VP of Immunology and Fibrosis
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Mar 2011
Agendia Hires David Macdonald as Chief Operating Officer, Mark Willig as Executive VP of North American Sales, and Doug Bradley as Vice President of Global Marketing
Diagnostics Personalized Medicine Personnel

HSMN NewsFeed - 1 Feb 2011
Constellation Pharmaceuticals Expands Leadership Team with Drug Development Industry Veterans
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Jan 2011
Regulus Therapeutics Promotes Garry E. Menzel, Ph.D., to Chief Operating Officer and Executive Vice President of Finance
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Dec 2010
Regulus Therapeutics Strengthens Immunology Leadership Team with New Key Appointment
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Oct 2010
Sanofi-Aventis Completes $10 Million Equity Investment in Regulus Therapeutics
Biopharmaceuticals

HSMN NewsFeed - 11 Oct 2010
Ipsen's Board of Directors Announces Jean-Luc Bélingard’s Departure and the Appointment of Marc de Garidel as New Chairman and CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Oct 2010
Mayo Researchers Find Biomarkers for Personalizing Radiation Cancer Treatment
Diagnostics Devices Oncology Personalized Medicine

HSMN NewsFeed - 21 Sep 2010
Athersys Receives Orphan Drug Designation for MultiStem in Graft vs. Host Disease
Regenerative Medicine FDA

HSMN NewsFeed - 20 Sep 2010
Athersys Announces Groundbreaking Data Showing Neuroprotective Effects of MultiStem Therapy for Traumatic Brain Injury
Regenerative Medicine Neurology

HSMN NewsFeed - 8 Sep 2010
XDx Appoints New Vice President of Corporate Development and Legal Affairs
Diagnostics Personnel

HSMN NewsFeed - 2 Aug 2010
Aragon Pharmaceuticals Appoints Richard A. Heyman CEO
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 2 Jun 2010
Constellation Pharmaceuticals Closes $22 Million in Series B Funding
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 11 Mar 2010
Illumina and Glenn Close Announce the First Full Coverage DNA Sequencing of a Named Female
Diagnostics

HSMN NewsFeed - 4 Mar 2010
iBio Appoints Vidadi Yusibov, Ph.D. Chief Scientific Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Mar 2010
iBio Appoints Philip K. Russell, M.D. to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Jan 2010
Ligand Completes Acquisition of Metabasis
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 21 Jan 2010
Genomic Health Announces Worldwide Availability of the Oncotype DX(R) Colon Cancer Test
Diagnostics Oncology

HSMN NewsFeed - 15 Jan 2010
Celgene Completes Acquisition of Gloucester Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 11 Jan 2010
Regulus Therapeutics Appoints Zachary A. Zimmerman, Ph.D., Director of Business Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Jan 2010
Acetylon Pharmaceuticals Tops Up Series A Financing with $2 Million Note And Appoints Simon Jones VP Biology and Preclinical Development and John van Duzer VP Chemistry and Manufacturing
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 5 Jan 2010
Inovio Appoints Dr. Mark Bagarazzi as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Dec 2009
FDA Broadens Clearance for Agendia's MammaPrint(R)
Diagnostics Oncology FDA

HSMN NewsFeed - 7 Dec 2009
Celgene to Acquire Gloucester Pharmaceuticals
Biopharmaceuticals Oncology Mergers & Acquisitions

HSMN NewsFeed - 17 Nov 2009
New Genomic Test for Coronary Artery Disease Now Available at The Heart & Vascular Center of Arizona
Diagnostics Cardiology

HSMN NewsFeed - 12 Nov 2009
Mirna Therapeutics Appoints Dr. Paul Lammers as President and CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Oct 2009
Ligand to Acquire Metabasis for Cash and Contingent Value Rights
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 20 Oct 2009
Bionovo Announces Publication of Data on Potential Increase in Breast Cancer Risk Due to the Inhibitory Effect of Tamoxifen Treatment on Estrogen Receptor Beta
Biopharmaceuticals Oncology

HSMN NewsFeed - 22 Sep 2009
Agendia Raises US $23 Million in Series E Financing
Diagnostics Venture Capital

HSMN NewsFeed - 7 Aug 2009
Acetylon Pharmaceuticals Raises $7.25 Million Series A to Develop Next-Generation Selective HDAC Inhibitors for Cancer and Rheumatoid Arthritis
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 5 Aug 2009
XDx Completes $14.4 Million Series G Financing
Diagnostics Venture Capital

HSMN NewsFeed - 30 Jul 2009
Cardium Announces New Orthobiologics Product Initiative Extending Gene Activated Matrix Technology to Deliver Bone Growth Factors
Devices Regenerative Medicine Wound Care

HSMN NewsFeed - 8 Jul 2009
Dicerna Pharmaceuticals Announces Appointment of Industry Veteran David Madden as Chairman of the Board
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Jun 2009
miRagen Therapeutics, Inc. Accomplishes Funding Milestones and Secures Series A Extension
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 23 Apr 2009
SEQUENOM Announces Cost Cutting Initiative in Genetic Analysis Business
Diagnostics

HSMN NewsFeed - 20 Apr 2009
Genomic Health Announces Study Confirming Prognostic Value of Oncotype DX(R) Recurrence Score(R) Result in Japanese Breast Cancer Patients
Diagnostics Oncology

HSMN NewsFeed - 18 Feb 2009
Agendia Publishes Direct Evidence That MammaPrint Predicts Benefit of Chemotherapy in Breast Cancer
Diagnostics Oncology

HSMN NewsFeed - 4 Feb 2009
Agendia's Breast Cancer Test MammaPrint(R) Standard of Care at Netherlands Cancer Institute - AVL
Diagnostics Oncology

HSMN NewsFeed - 8 Jan 2009
Agendia Appoints New Chief Financial Officer
Diagnostics Oncology Personnel

HSMN NewsFeed - 12 Dec 2008
Agendia's MammaPrint(R) Predicts Response to Neoadjuvant Chemotherapy in Breast Cancer
Diagnostics Oncology

HSMN NewsFeed - 11 Sep 2008
bioMerieux Gains Critical Oncology and Theranostics Capabilities with the Acquisition of Molecular Diagnostics Company AviaraDx
Diagnostics Oncology Mergers & Acquisitions

HSMN NewsFeed - 5 Sep 2008
Positive SPA Reply From the FDA for TopoTarget's Pivotal Trial With Belinostat in PTCL
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 4 Sep 2008
Agendia Launches TargetPrint(R) for Breast Cancer Patients
Diagnostics Oncology

HSMN NewsFeed - 27 Aug 2008
XDx's AlloMap(R) Gene Expression Test Cleared by U.S. Food and Drug Administration (FDA)
Diagnostics FDA

HSMN NewsFeed - 4 Aug 2008
Expression Genetics Inc., Specializing in DNA/RNAi Delivery and Therapeutics, Completes $12M Series B Financing
Biopharmaceuticals Drug Delivery Venture Capital

HSMN NewsFeed - 31 Jul 2008
FDA Clears the Pathwork(R) Tissue of Origin Test for Hard-To-Identify Tumors
Diagnostics Oncology FDA

HSMN NewsFeed - 15 Jul 2008
Agendia and Ferrer Announce Exclusive Agreement for Sales of Cancer Diagnostic Services in Four Major European Markets
Diagnostics

HSMN NewsFeed - 7 Jul 2008
Inovio Biomedical and VGX Pharmaceuticals Sign Merger Agreement
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 16 Jun 2008
Tercica Announces Results from Increlex(R) IGFD Patient Registry and Other Increlex(R) Studies at the 90th Meeting of the Endocrine Society
Biopharmaceuticals

HSMN NewsFeed - 30 May 2008
New Data on MAGE-A3 Cancer Immunotherapy Support Potential Novel Options of Treating Non-Small Cell Lung Cancer and Melanoma
Biopharmaceuticals Oncology

HSMN NewsFeed - 1 May 2008
Regenesis Biomedical Advances Corporate Strategy by Appointing Vice President of Marketing
Devices Wound Care Personnel

HSMN NewsFeed - 29 Apr 2008
Constellation Pharmaceuticals Closes $32 Million in Series A Funding
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 3 Apr 2008
Asuragen Launches Mirna Therapeutics
Diagnostics Biopharmaceuticals

HSMN NewsFeed - 13 Mar 2008
AVI BioPharma Announces Acquisition of Ercole Biotech
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 7 Mar 2008
Allegro Diagnostics Closes $4 Million Round to Develop and Commercialize Lung Cancer Molecular Diagnostics Based on Gene Expression
Diagnostics Venture Capital

HSMN NewsFeed - 7 Feb 2008
EMEA Accepts for Review Vidaza(R) Marketing Authorization Application for Higher-Risk Myelodysplastic Syndromes
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 30 Jan 2008
Therapeutic DNA Vaccine Company, Inovio Biomedical, Promotes Punit Dhillon to Vice President of Finance & Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Jan 2008
Pharmion Submits European Marketing Authorization Application (MAA) for Vidaza(R) in Patients with Higher-Risk Myelodysplastic Syndromes (MDS)
Biopharmaceuticals Oncology

HSMN NewsFeed - 8 Jan 2008
Primera Biosystems Raises $21 Million in Series B Private Round
Diagnostics Venture Capital

HSMN NewsFeed - 7 Jan 2008
Genizon BioSciences Secures $31 Million in Additional Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 20 Dec 2007
Athersys Receives IND Authorization for MultiStem in Acute Myocardial Infarction
Regenerative Medicine Cardiology

HSMN NewsFeed - 17 Dec 2007
MammaPrint(R) Breast Cancer Test Shown To Be Powerful Tool for Prognosis Prediction in Postmenopausal Breast Cancer Patients
Diagnostics Oncology

HSMN NewsFeed - 17 Dec 2007
Multiple Studies Presented at San Antonio Breast Cancer Symposium Reinforce Clinical Utility of Oncotype DX(R)
Biopharmaceuticals Oncology

HSMN NewsFeed - 14 Dec 2007
Study Shows MammaPrint(R) Breast Cancer Test Provides Benefits to Patients from Personalized Treatment Regimen
Diagnostics Oncology

HSMN NewsFeed - 12 Dec 2007
Agendia's MammaPrint(R), the Only FDA-Cleared Breast Cancer Prognosis Test, is Now Widely Available to U.S. Patients
Diagnostics Oncology FDA

HSMN NewsFeed - 26 Nov 2007
Cytheris Appoints Richard Keatinge as Chief Business Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Sep 2007
Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease
Biopharmaceuticals

HSMN NewsFeed - 13 Sep 2007
PTC Therapeutics Announces $20 Million Strategic Investment From Celgene Corporation
Biopharmaceuticals

HSMN NewsFeed - 5 Sep 2007
Athersys Elects Jeff Randall to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Sep 2007
Athersys Announces Completion of Name Change and New Ticker Symbol, AHYS
Biopharmaceuticals

HSMN NewsFeed - 5 Sep 2007
Bar Harbor BioTechnology Inc. Completes Series A Financing for Product Launch
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 30 Aug 2007
Entelos Acquires Iconix Biosciences, Inc.
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 29 Aug 2007
Pharmion's Oral Azacitidine Granted Fast Track Status for Myelodysplastic Syndromes
Biopharmaceuticals FDA Oncology

HSMN NewsFeed - 24 Aug 2007
DNA Sequencing Equipment Market to Fragment and Grow as Competition, New Technologies Develop
Biopharmaceuticals

HSMN NewsFeed - 21 Aug 2007
Inovio Biomedical Appoints Dr. Michael Fons as Vice President, Corporate Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Aug 2007
IPSEN: Increlex(R) Receives Marketing Authorisation in the European Union
Biopharmaceuticals Regulatory

HSMN NewsFeed - 8 Aug 2007
Tercica Receives Marketing Approval for Increlex in the European Union
Biopharmaceuticals Endocrinology Regulatory

HSMN NewsFeed - 2 Aug 2007
PTC Therapeutics Appoints Theresa Natalicchio as Senior Vice President of Marketing and Sales
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Jul 2007
Tercica Announces Agreement with Genentech for Worldwide Growth Hormone and IGF-1 Combination Product Development and Commercialization
Biopharmaceuticals

HSMN NewsFeed - 21 Jun 2007
Neurologix Announces Publication of Landmark Gene Therapy Study Demonstrating Safety and Statistically Significant Improvement in Patients With Advanced Parkinson's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 19 Jun 2007
Inovio Biomedical's Selective Electrochemical Tumor Ablation Therapy Shows Safety, Tolerability, and Significant Complete Responses in Breast Cancer Study
Devices Biopharmaceuticals Oncology

HSMN NewsFeed - 18 Jun 2007
Gene Logic Collaboration Reveals Genomic Predictors of Parkinson's Disease
Diagnostics Biopharmaceuticals Neurology

HSMN NewsFeed - 7 Jun 2007
In 2009 Exonhit Aims to ask for Market Clearance in Europe for a Blood Diagnostic Test for Alzheimer's Disease
Diagnostics Neurology

HSMN NewsFeed - 5 Jun 2007
Inovio Biomedical Stops Enrollment of Phase III Clinical Trials for Head & Neck Cancer
Devices Drug Delivery Oncology

HSMN NewsFeed - 3 Jun 2007
Genomic Health, Inc. Announces Positive Results from First Study Using Oncotype DX(TM) in Node-Positive Breast Cancer Patients
Diagnostics Biopharmaceuticals Oncology

HSMN NewsFeed - 3 Jun 2007
Genentech Provides Update on Pipeline Agents at the American Society of Clinical Oncology Meeting
Biopharmaceuticals Oncology

HSMN NewsFeed - 3 Jun 2007
PTC Therapeutics Presents Phase 1 Results of its Novel VEGF Inhibitor, PTC299, at 43rd American Society of Clinical Oncology (ASCO) Annual Meeting
Biopharmaceuticals Oncology

HSMN NewsFeed - 2 Jun 2007
Clinical Data Reported on Vidaza in Hematologic Malignancies and Advanced Solid Tumors
Biopharmaceuticals Oncology

HSMN NewsFeed - 25 May 2007
Ipsen: Increlex(R) Receives CHMP Positive Opinion for the Treatment of Severe Primary IGF-1 Deficiency
Biopharmaceuticals Regulatory

HSMN NewsFeed - 22 May 2007
Inovio Biomedical's DNA Delivery Technology Significantly Enhances Potency of Gene-Based Prostate Cancer Vaccine
Biopharmaceuticals Oncology Drug Delivery

HSMN NewsFeed - 14 May 2007
Lee Babiss Appointed Head of Global Pharma Research at Roche
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 May 2007
La Jolla Pharmaceutical Company Names Niv Caviar Chief Business and Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 May 2007
Ceregene Presents Interim Phase 1 Clinical Data of CERE-110 for the Treatment of Alzheimer's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 2 May 2007
AVI BioPharma and Ercole Biotech Announce License and Drug Development Agreement for Duchenne Muscular Dystrophy and Beta Thalassemia
Biopharmaceuticals

HSMN NewsFeed - 2 May 2007
PTC Therapeutics Announces Promotion of Neil Almstead to Senior Vice President of Chemistry and CMC
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Apr 2007
Affymetrix Clinical Services Laboratory Receives CLIA Certification
Diagnostics

HSMN NewsFeed - 19 Apr 2007
Metabolex Raises $32 Million to Accelerate Clinical Development Programs for Its Pipeline of Drug Candidates in Metabolic Disease
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 12 Mar 2007
Cytochroma appoints co-founder Dr. P. Martin Petkovich as full-time Chief Scientific Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Feb 2007
Celera Presents Data Validating Its Metastasis Score as a Molecular Prognostic Tool in Breast Cancer
Diagnostics Oncology

HSMN NewsFeed - 20 Feb 2007
Althea Technologies Announces the Development of a Diagnostic Capable of Differentiating Multiple Forms of Childhood Cancer
Diagnostics Oncology

HSMN NewsFeed - 6 Feb 2007
Agendia Receives U.S. FDA Clearance for MammaPrint Breast Cancer Diagnostic Test
Diagnostics FDA

HSMN NewsFeed - 29 Jan 2007
Pharmion Corporation Announces FDA Approval of Vidaza NDA Supplement for IV Administration
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 24 Jan 2007
Cephalon Comments on Study of its Leukemia Treatment Led by National Cancer Institute Cooperative Group
Biopharmaceuticals Oncology

HSMN NewsFeed - 10 Jan 2007
Panacea Pharmaceuticals Appoints Pamela Harris, MD, Vice President Medical and Clinical Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Jan 2007
Althea Technologies Closes $23 Million Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 8 Jan 2007
PTC Therapeutics Announces Strategic Drug Discovery Collaboration with Pfizer Utilizing PTC's GEMS Technology Platform
Biopharmaceuticals Licensing

HSMN NewsFeed - 4 Jan 2007
Avalon Pharmaceuticals Names Clinical Advisory Board
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Dec 2006
Quest Diagnostics Launches Test to Help Oncologists Predict Risk of Breast Cancer Recurrence in Women with Estrogen Receptor (ER)-Positive, Lymph Node- Negative Cancers
Diagnostics Oncology

HSMN NewsFeed - 8 Dec 2006
49 Abstracts Evaluating Revlimid(R) To Be Presented at The 48th American Society of Hematology Meeting
Biopharmaceuticals Oncology

HSMN NewsFeed - 4 Dec 2006
Edwards' Angiogenesis Program to Be Acquired by Sangamo
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 30 Nov 2006
U.S. Court of Appeals Allows Enzo Biochem Patent Infringement Suit to Proceed
Diagnostics Litigation

HSMN NewsFeed - 21 Nov 2006
Intradigm Announces Significant Enhancements of the Company Capabilities, a New Series A Financing and Important Addition to Senior Management Team
Biopharmaceuticals Personnel Venture Capital

HSMN NewsFeed - 16 Nov 2006
CuraGen and TopoTarget Announce Initiation of NCI-sponsored Phase II Clinical Trial of PXD101 for Myelodysplastic Syndrome
Biopharmaceuticals Oncology

HSMN NewsFeed - 6 Nov 2006
Acumen Pharmaceuticals Names Dr. William F. Goure Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Nov 2006
Avalon Pharmaceuticals Names Todd R. Golub, M.D. as Chairman and Member of Its Scientific Advisory Board
Biopharmaceuticals Personnel

HSMN NewsFeed - 31 Oct 2006
Gene Expression Test From XDx Now Indicated for Earlier Use and Prediction of Acute Cellular Rejection
Diagnostics Cardiology Reimbursement

HSMN NewsFeed - 17 Oct 2006
Inovio Biomedical Acquires Rights to DNA Vaccine Licenses and Intellectual Property from Valentis
Biopharmaceuticals Drug Delivery Licensing

HSMN NewsFeed - 27 Sep 2006
Avalon Pharmaceuticals Appoints David D. Muth to Executive Vice President, Chief Business Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Sep 2006
Panacea Pharmaceuticals Announces Appointments of Christine L. Brauer, Ph.D. as Vice President, Regulatory Affairs; and Jefferey Jones, M.S., as Director of Quality
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Jul 2006
Geron Presents New Data That Document Progress in Development of Therapeutic Products from Human Embryonic Stem Cells
Biopharmaceuticals Regenerative Medicine

HSMN NewsFeed - 11 May 2006
Federal Appeals Court Rules in Cardium's Favor Over Boston Scientific and Arch Development on Patents for the Treatment of Heart Disease
Devices Cardiology Litigation

Return to NewsFeed

Additional items found! 159

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 159 additional stories matching:
gene expression
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.